1. Home
  2. ASPN vs NVAX Comparison

ASPN vs NVAX Comparison

Compare ASPN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

HOLD

Current Price

$3.72

Market Cap

273.3M

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.28

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPN
NVAX
Founded
2001
1987
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.3M
1.6B
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
ASPN
NVAX
Price
$3.72
$8.28
Analyst Decision
Strong Buy
Hold
Analyst Count
4
9
Target Price
$4.25
$11.33
AVG Volume (30 Days)
1.1M
3.5M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
$271,103,000.00
$1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$50.03
N/A
P/E Ratio
N/A
$3.09
Revenue Growth
N/A
64.69
52 Week Low
$2.30
$5.01
52 Week High
$9.78
$11.85

Technical Indicators

Market Signals
Indicator
ASPN
NVAX
Relative Strength Index (RSI) 59.91 41.51
Support Level $2.95 $8.01
Resistance Level $3.80 $8.45
Average True Range (ATR) 0.21 0.46
MACD 0.06 -0.16
Stochastic Oscillator 76.06 30.39

Price Performance

Historical Comparison
ASPN
NVAX

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: